Bingbing Zhao
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 25, 2026
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
Journal: Communications medicine
Published: September 18, 2025
Treatment patterns and prognosis of patients with locally advanced vulvar cancer: a retrospective cohort study of the SEER database and a Chinese multicenter registry.
Journal: Gynecologic oncology
Published: September 10, 2025
ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis.
Journal: Biochemical pharmacology
Published: May 31, 2025
Withdrawal notice to "ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis" [Biochemical Pharmacology 237 (2025) 116949].
Journal: Biochemical pharmacology
Published: May 27, 2025
Phosphorylated IRF3 promotes GSDME-mediated pyroptosis through RIPK1/FADD/caspase-8 complex formation during mitotic arrest in ovarian cancer.
Journal: Cell communication and signaling : CCS
Published: March 20, 2025
Withdrawal notice to: ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis.
Withdrawal notice to: ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis.
Journal: Biochemical pharmacology
Published: January 27, 2025
Dynamic changes in peripheral blood immunophenotyping and its prognostic value in cervical cancer patients undergoing immune checkpoint blockade therapy.
Journal: Discover oncology
Published: September 27, 2024
piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.
Journal: Technology in cancer research & treatment
Published: May 06, 2024
Identification of PDZD11 as a Potential Biomarker Associated with Immune Infiltration for Diagnosis and Prognosis in Epithelial Ovarian Cancer.
Journal: International journal of general medicine
Published: January 13, 2024
Influences of Total Alkaloids in Caulis Mahoniae on Proliferation and Apoptosis of Cervical Cancer Cells and the Caspase-3 Expression.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: July 04, 2022
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer.
Journal: Journal of ovarian research
Published: December 06, 2021
Last Updated: 09/26/2026